|
Volumn 181, Issue 1, 2001, Pages 81-86
|
Long-term outcome study of growth factor-treated pressure ulcers
|
Author keywords
Clinical trial; Cytokines; Growth factors; Outcome study; Wound healing
|
Indexed keywords
PLACEBO;
RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;
RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DECUBITUS;
DOSE TIME EFFECT RELATION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FOLLOW UP;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOTHERAPY;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
WOUND HEALING;
ADMINISTRATION, TOPICAL;
FIBROBLAST GROWTH FACTOR 2;
FOLLOW-UP STUDIES;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
GROWTH SUBSTANCES;
HUMANS;
PRESSURE ULCER;
PROSPECTIVE STUDIES;
TIME FACTORS;
TREATMENT OUTCOME;
WOUND HEALING;
|
EID: 0035089440
PISSN: 00029610
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9610(00)00536-5 Document Type: Article |
Times cited : (53)
|
References (19)
|